
· Executive Brief
National Infant Immunization Week 2026
Use the observance to test whether prevention, readiness, escalation, and learning operate as one connected system.

Leadership signal
Recognition becomes useful when leaders inspect the real route.
A safety-focused observance is a useful point to compare policy with real work. Include frontline teams, facilities, operations, clinical leadership, and other relevant partners. Identify where the process depends on memory, informal workarounds, or an unowned handoff.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Infant immunization is a reliability system
Infant immunization depends on a long chain of operating steps. A vaccine must be stored at the right temperature, a record must show what is due, a reminder must reach the family, a clinician must recommend clearly and the visit must happen on time. A failure at any link can leave an infant unprotected without anyone noticing. National Infant Immunization Week is a useful prompt to inspect that chain as one system. The week is short, but the chain it examines runs every day of the year.
Coverage gaps are real even in high-income settings. Among U.S. children aged 19–35 months in 2023, coverage for the combined 7-vaccine series was only 78.5%.[14] Disparities by income, maternal education, insurance and provider facility type persisted, though their absolute magnitude was small.[14]
Newer protections face their own gaps. Respiratory syncytial virus infection is the leading cause of infant hospitalizations in the United States, and families can now choose maternal vaccination during pregnancy or an antibody shot for infants after birth.[1] In a national survey, 59.8% of parents reported a positive intention toward the infant antibody shot.[1] Among eligible pregnant women, 55.5% reported a positive intention toward maternal vaccination.[1]
The long-run payoff from reliable programs is substantial. A 30-year cohort analysis in Beijing estimated hepatitis B vaccine effectiveness of 95.36% by 20 years after birth under a program of universal infant immunization.[13] This section adds published evidence of that kind to the executive guidance above. It concentrates on the levers health systems control: records, reminders, storage, communication, access and measurement. Each lever has an owner, a measure and a known failure pattern.
Current evidence
What the evidence shows about coverage, hesitancy and missed doses
Coverage depends on what families pay and where they live. In Beijing, where four vaccines recommended by WHO for national programs are self-funded, coverage among children aged 1–6 years was 48.5% for pneumococcal conjugate vaccine and 47.4% for Hib vaccine.[8] Coverage was 43.5% for rotavirus vaccine and 89.3% for varicella vaccine.[8] The authors described coverage of the first three as suboptimal, with evident regional disparities.[8] Cost is a structural barrier that communication alone cannot remove.
Hesitancy appears early in a child’s life. Among 452 parents or guardians of infants in Piauí, Brazil, overall vaccine hesitancy was 31.4%.[6] Hesitancy was 25.2% specific to the COVID-19 vaccine and 6.2% related to other vaccines in the childhood schedule.[6] Parents of children aged seven to 12 months had higher odds of hesitancy (adjusted odds ratio 2.16), while high knowledge was associated with lower odds (adjusted odds ratio 0.39).[6] Hesitancy that rises during the first year argues for addressing concerns early, at prenatal and newborn visits.
Hesitancy can change after a family experience. Among 154 parents of children with autism spectrum disorder or other developmental delays at two large hospitals, reported vaccine refusal increased from 3.9% before diagnosis to 9.7% after diagnosis.[12] Yet 88.3% of those parents disagreed or strongly disagreed that vaccines cause autism or developmental disorders.[12] Concern and belief do not always move together, which matters for how clinicians respond. Clinicians may need to address fear and uncertainty rather than correct a stated belief.
Missed opportunities often occur after consent, not before it. In Palau’s school-based HPV program, 93% of consent forms were returned and 70% of girls received consent, but only 42% received at least 1 dose according to the immunization information system.[11] Responses were missing on 17% of returned forms, and refusals rose to 24% of returned forms in 2023-2024.[11] The program serves older children, but the pattern of consent without a completed dose applies to infant visits as well.
Series completion is a separate failure point. In Alaska, HPV vaccine series completion among adolescents aged 13–15 years ranged from 32% to 39% between 2018 and 2023, while 48% had initiated vaccination.[10] The authors described a substantial decline between initiation and completion.[10] For multi-dose infant schedules, the equivalent measure is on-time completion of each series by 24 months, not first-dose uptake. Initiation without completion means the investment in a first visit is only partly realized.
Figure 1
Early childhood vaccine coverage varies widely by setting and by vaccine
Percent of children with the vaccine or series, as reported in each study. Values are copied from the cited studies [8], [14]; none is estimated.
Data note. The four Beijing values come from one study and can be compared with each other, but the U.S. series value uses a different population, age range, definition and payment context, so comparison with it is an indirect comparison.
Limitation. Coverage definitions differ (a combined series versus single vaccines), and the Beijing vaccines are self-funded, unlike most U.S. infant vaccines.
Figure data (5 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Combined 7-vaccine series, U.S. | 78.5% | U.S. children aged 19–35 months in 2023, national survey | [14] |
| Varicella vaccine, Beijing | 89.3% | Children aged 1–6 years, Beijing, self-funded vaccine, 2025 survey linked to registry records | [8] |
| Pneumococcal conjugate vaccine, Beijing | 48.5% | Same Beijing study, self-funded vaccine | [8] |
| Hib vaccine, Beijing | 47.4% | Same Beijing study, self-funded vaccine | [8] |
| Rotavirus vaccine, Beijing | 43.5% | Same Beijing study, self-funded vaccine | [8] |

Continuum of care
Records and reminders keep infants on schedule
Infant immunization runs across many encounters: the birth hospital, newborn visits, well-child checks, urgent care and sometimes public health clinics. Each encounter can either catch a due dose or miss it. Immunization information systems are the shared record that makes catch-up possible across those settings, provided every vaccinating site reads from and writes to them.
Information systems already underpin rigorous program evaluation. Researchers linked survey responses from 4,182 Beijing guardians to individual vaccination histories in the city’s immunization information system.[8] A 30-year Beijing cohort combined the immunization information system with disease reporting data to evaluate universal infant hepatitis B immunization and an adolescent booster.[13] Vaccine effectiveness was estimated at 64.43% within 10 years of birth and 67.35% by 30 years.[13] Complete shared records can answer program questions that individual practices cannot.
Records help only when they reach the point of care. In a pilot at six community pharmacies in Washington State, the most adopted decision support component was a data pull from the immunization information system into the dispensing system, at 78%.[9] Staff recommendations for HPV vaccination increased from 77% to 100%.[9] The authors cautioned that workflow supports alone may be insufficient to raise vaccination rates without strategies that actively bring patients in.[9] The pilot ran from April to August 2024 with 13 staff completing paired surveys, so the results are early.[9]
Reminder-recall is still far from universal. Among 227 nurses and medical assistants in Montana clinics participating in the Vaccines for Children program, about 53.7% reported that their clinics had reminder/recall systems.[15] The authors identified widespread adoption of reminder/recall systems as a promising initiative for rural states.[15] The Beijing authors similarly called for strengthened reminder systems alongside free vaccination policies.[8] Reminder-recall is a low-cost system that depends more on ownership than on technology.
The operating standard is simple to state. Every infant in a panel should have a next due dose, a due date and a named owner. Systems should reconcile their records with the state registry, run recall lists on a fixed cadence and review how often infants leave a visit with an overdue dose that was not given. Each of those checks turns a missed opportunity into a visible exception that someone is expected to close. Registry reconciliation also protects families who change practices or insurance, a common event in the first two years.
Figure 3
Why the pathway breaks
People
- Clinicians not trained or observed in hesitancy conversations
- Storage responsibilities without backup coverage
- Families with several young children and limited time
Process
- No reminder-recall in about half of surveyed clinics
- Consent obtained but dose never given
- No handoff between prenatal and pediatric teams on RSV options
Technology
- Registry data not pulled into point-of-care workflows
- Storage units without continuous temperature monitoring or alarms
- Paper stock registers without real-time documentation
Environment
- Power outages and heat exposure
- Suburban and rural residence with fewer contacts
- Social media misinformation
Policy
- Out-of-pocket cost for some vaccines
- No dedicated vaccine transport or trained drivers
- Emergency storage plans not required or tested
Measurement
- Coverage tracked by first dose rather than series completion
- Results not stratified by insurance, place or disability
- Temperature excursions not documented
Unranked qualitative cause-and-effect diagram for the outcome in the box: Infants miss or delay recommended doses and are not fully protected by 24 months Causes are assembled from the cited literature [1], [2], [3], [4], [7], [8], [9], [10], [11], [15]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Clinicians not trained or observed in hesitancy conversations; Storage responsibilities without backup coverage; Families with several young children and limited time |
| Process | No reminder-recall in about half of surveyed clinics; Consent obtained but dose never given; No handoff between prenatal and pediatric teams on RSV options |
| Technology | Registry data not pulled into point-of-care workflows; Storage units without continuous temperature monitoring or alarms; Paper stock registers without real-time documentation |
| Environment | Power outages and heat exposure; Suburban and rural residence with fewer contacts; Social media misinformation |
| Policy | Out-of-pocket cost for some vaccines; No dedicated vaccine transport or trained drivers; Emergency storage plans not required or tested |
| Measurement | Coverage tracked by first dose rather than series completion; Results not stratified by insurance, place or disability; Temperature excursions not documented |
Access
Access means a dose that is affordable, nearby and still potent
Access in infant immunization depends on cost, location and the number of places a family can receive a dose. In Beijing, the authors recommended free vaccination policies for self-funded vaccines whose coverage remained suboptimal.[8] In the United States, the Montana survey of Vaccines for Children clinics shows that program participation does not by itself guarantee reminder systems, since only about half reported having them.[15] Cost removal and operational follow-through are separate requirements.
Insurance and facility type also shape U.S. coverage. The national 2023 analysis found coverage disparities by health insurance type and provider facility type, as well as by household income and maternal education.[14] The authors called for targeted efforts to address income, insurance, maternal education and provider-related barriers to sustain equitable coverage.[14] For health systems, provider-related barriers are the part most directly within their control.
Rural access requires more than clinic hours. Montana nurses identified infrequent wellness visits, misinformation from social media and vaccine safety concerns as barriers to uptake.[15] Infrequent visits matter most for infants, whose schedules require repeated contact in the first two years. Extended hours, combined visits and outreach for families who miss a well-child check are practical responses. Each of these options should be tracked for the infants it actually reaches.
Pharmacies add access points but need integration. The Washington pharmacy pilot found routine recommendation at ages 9–10 rising from 15% to 46% after decision support was deployed.[9] Vaccination audit data showed heterogeneous changes across sites.[9] Most infant doses are delivered in medical homes, so the lesson for infant care is shared records with every vaccinating site rather than a shift of infant doses to pharmacies. Pharmacies can still help by checking registry status for parents and older siblings.
Supply access belongs here as well, because a vaccine stored outside its range may be on the shelf but no longer protective. In a laboratory study, bivalent oral polio vaccine kept at 2–4°C sustained potency in 100% of samples for 6 months.[5] At 27–29°C, 50% of samples sustained potency after 2 weeks, and at atmospheric temperatures of 22–44°C titers dropped significantly within a week.[5] Power reliability and storage discipline are therefore access issues wherever outages or heat occur. Storage audits should include after-hours response, not only daytime readings.
Executive guidance · System route
Map the path from first contact to verified follow-through.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Identify the concern
- Activate prevention
- Include the family route
- Escalate and respond
- Review and improve
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Identify the concern
Define approved ways to recognize and report a concern without asking unqualified staff to make clinical or legal determinations.
Activate prevention
Make locally approved controls, tools, education, and responsibilities visible where the work occurs.
Include the family route
Use locally approved methods to include the patient, family, or authorized caregiver as appropriate while keeping role, privacy, and next-step ownership clear.
Escalate and respond
Route the concern to the qualified owner, acknowledge receipt, and preserve visibility until the next action is accepted.
Review and improve
Examine exceptions, near misses, workarounds, and delays using a learning approach and transparent action ownership.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Identify the concern | Define approved ways to recognize and report a concern without asking unqualified staff to make clinical or legal determinations. |
| Activate prevention | Make locally approved controls, tools, education, and responsibilities visible where the work occurs. |
| Include the family route | Use locally approved methods to include the patient, family, or authorized caregiver as appropriate while keeping role, privacy, and next-step ownership clear. |
| Escalate and respond | Route the concern to the qualified owner, acknowledge receipt, and preserve visibility until the next action is accepted. |
| Review and improve | Examine exceptions, near misses, workarounds, and delays using a learning approach and transparent action ownership. |
Equity and trust
Equity requires stratified measures and community leadership
Disparities persist even where overall coverage is high. The U.S. analysis of children aged 19–35 months found disparities by income-to-poverty ratio, maternal education, insurance type and provider facility type.[14] Their absolute magnitude was very small, with concentration indices of 0.04 or less.[14] The authors concluded that inequities remain statistically measurable while limited in absolute scale.[14] Health systems should watch whether those small gaps widen as hesitancy shifts.
Community-led programs can reverse expected gaps. In Alaska, American Indian and Alaska Native adolescents had significantly higher HPV vaccine series completion than non-Native peers, at 48% versus 29%.[10] The authors linked the difference to community-centered, Tribal-led vaccination efforts and noted that it challenges assumptions about access.[10] They also reported persistent regional and urban-rural disparities and recent declines in coverage among Native adolescents.[10] Tribal health organizations offer a model of trusted, locally governed delivery that other systems can learn from through partnership rather than imitation.
Geography shapes coverage in other systems too. Beijing children living in suburban and outer suburban areas had lower coverage of pneumococcal conjugate, Hib and rotavirus vaccines, with adjusted odds ratios ranging from 0.160 to 0.929 across associated factors.[8] Older age and a greater number of children in the household were also associated with lower coverage.[8] Families with several young children may need scheduling support rather than more information.
Families of children with developmental conditions need deliberate attention. In the study of parents of children with autism spectrum disorder and other developmental delays, hesitancy or refusal after diagnosis showed no independent associations with several family factors.[12] Those factors were parental education, income, source of vaccine information and depression or anxiety scores.[12] The authors called for tailored education and communication to prevent refusal for both diagnosed children and their siblings.[12] Younger siblings are often infants, so pediatric and developmental services should share a plan.
The executive practice is to stratify on-time coverage by the second birthday by race, ethnicity, language, insurance, neighborhood and disability status. Results should be reviewed with community and Tribal partners where they exist, with privacy protections in place. Data on disability status may require linkage to specialty care records, which should be planned with privacy review. Equity work succeeds when the communities with the lowest coverage help design the response.

Human infrastructure
Nurses, medical assistants and storage leads carry the program
Immunization services depend heavily on nurses and medical assistants, especially in rural states. In Montana, 90% of surveyed nurses strongly agreed or agreed that the HPV vaccine is important and had confidence in its safety.[15] Nurses reported more parental refusal or delay for male patients, and the authors recommended training nurses in evidence-based techniques to provide strong recommendations.[15] Their views should shape the protocols they are asked to deliver.
Communication skill can be trained, but outcomes need careful measurement. In a randomized study of online training, 54 of 58 eligible pediatrics and medicine-pediatrics residents (93%) enrolled.[7] Residents trained in the Announce-Inquire-Mirror-Secure method showed more of the targeted behaviors than control-trained residents.[7] Standardized patient ratings of communication did not differ between groups, and confidence rose in both arms.[7] Training should therefore be judged on observed behavior, not self-reported confidence.
Cold chain work is skilled work. In Korea, an audit of 53 immunization providers found that all had dedicated vaccine refrigerators, but 73.6% had continuous temperature monitoring on all refrigeration units.[2] Alarm systems were present at 83.0% of sites, and 52.8% had documented emergency plans such as a backup system.[2] The authors called for strengthened training and oversight in monitoring, alarms and emergency backup provisions.[2] Monitoring, alarms and emergency plans are exactly the safeguards that fail silently until a vaccine loss is discovered.
Transport and front-line storage are where staff support is thinnest. Across 48 distribution routes in Ukraine, compliance with the recommended temperature range was approximately 100% at national and regional stores.[4] Compliance during storage fell to 88.8% at primary healthcare center sub-offices, where 20 freeze and five heat alarms were recorded.[4] The authors cited equipment malfunctions, gaps in knowledge, lack of procedures and power outages as probable contributors.[4] Eight transits to primary healthcare centers and 15 to sub-offices failed to maintain the required range throughout transit.[4]
Pharmacy and clinic staff need the same support. In the Washington pilot, staff self-efficacy for setting vaccination goals improved from a mean of 3.4 to 4.2 on a five-point scale.[9] Executives should count vaccine coordinators, storage leads and trained communicators as part of the immunization workforce. Each role needs protected time, backup coverage and a clear escalation route when a refrigerator alarm sounds after hours.
Executive guidance · Operating dashboard
Measure whether the operating route works as intended.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Prevention reliability
Are approved preventive steps usable and consistently supported in the real work environment?
- Candidate local measure
- Locally defined control checks, barriers, exceptions, and corrective-action status.
Executive guidance · Signal
Readiness
Can the right team, tool, information, and backup be reached when needed?
- Candidate local measure
- Readiness checks, unavailable resources, response barriers, and escalations.
Executive guidance · Signal
Family-centered usability
Can patients, families, or authorized caregivers understand the entry point, responsible team, and next step where appropriate?
- Candidate local measure
- Locally defined communication barriers, repeated contacts, support requests, unresolved handoffs, and experience feedback.
Executive guidance · Signal
Learning system
Are recurring patterns translated into owned improvements?
- Candidate local measure
- Review completion, assigned actions, overdue actions, verified changes, and shared learning.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Prevention reliability | Executive sponsor and operational lead |
| Readiness | Operational owner and participating teams |
| Family-centered usability | Sending and receiving owners |
| Learning system | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Keep work owned when it crosses a boundary.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Confirm the approved communication route for the patient, family, or authorized caregiver as locally appropriate.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Ask questions that connect intent, ownership, and results.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Prevention reliability | Are approved preventive steps usable and consistently supported in the real work environment? | Executive sponsor and operational lead | At campaign launch and close |
| Readiness | Can the right team, tool, information, and backup be reached when needed? | Operational owner and participating teams | At a locally defined cadence |
| Family-centered usability | Can patients, families, or authorized caregivers understand the entry point, responsible team, and next step where appropriate? | Sending and receiving owners | At a locally defined cadence |
| Learning system | Are recurring patterns translated into owned improvements? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable infant immunization pathway
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Registry reconciliation at every vaccinating site | Due doses are invisible at the point of care | Ambulatory informatics lead | Share of encounters with a current registry query |
| Reminder-recall on a fixed cadence | Infants fall behind between visits | Pediatric practice manager | Recall lists run and contacted on schedule; overdue rate at 24 months |
| Missed-opportunity review | Consent or a visit occurs without the due dose | Pediatric medical director | Visits with an overdue dose not given, reviewed monthly |
| Continuous temperature monitoring with alarms and tested backup | Vaccines lose potency without detection | Pharmacy or vaccine coordinator | Monitored units, alarm response times and documented excursions |
| Prenatal-to-pediatric handoff for RSV protection | Infants receive neither maternal nor infant protection | Obstetric and pediatric service line leaders | Share of newborns with documented maternal vaccination or infant immunization |
| Observed communication training | Hesitant families receive weak or inconsistent recommendations | Clinical education director | Observed use of the communication method in practice |
| Stratified coverage reporting | Gaps by insurance, place or disability stay hidden | Population health director | Quarterly coverage at 24 months by group |
Control points derived from the cited evidence [1], [2], [3], [4], [7], [9], [11], [14], [15] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
A strong recommendation is still the most useful message
Clinician recommendation remains a powerful lever. In the national RSV survey, 27.0% of parents with negative or unsure intention would probably or definitely accept the infant antibody shot after a strong practitioner recommendation.[1] Among pregnant women with negative or unsure intention, 35.8% would accept maternal vaccination after such a recommendation.[1] Top reasons for negative or unsure intentions included lack of information and safety concerns.[1] Recommendation quality is therefore a measurable operating behavior, not only a personal style.
Family preferences can guide how options are presented. More parents preferred maternal vaccination (48.3%) than the infant antibody shot (9.4%), and pregnant women showed the same pattern (58.2% versus 6.2%).[1] Prenatal and pediatric teams therefore need a shared message and a documented handoff. A family that does not receive maternal vaccination in pregnancy should be offered the infant option after birth. Each declined option should be recorded so that the next clinician knows to revisit it.
Knowledge is associated with lower hesitancy. In the Brazilian infant study, moderate knowledge was most common (55.8%), and high knowledge (35.4%) was associated with lower odds of hesitancy.[6] The authors emphasized understanding of vaccine-preventable diseases, safety and expected reactions.[6] Those topics map directly to what families need to hear at newborn and early infant visits. Teams can build short, consistent explanations of those topics into each early visit.
Communication must address specific beliefs. Among parents of children with developmental conditions, the main reason given for hesitancy or refusal was a belief linking vaccines to the child’s neurodevelopmental condition.[12] Montana nurses named misinformation from social media as a barrier and suggested using social media to share consistent messages.[15] Messages should be consistent across the birth hospital, pediatric office and public channels. Clinicians should be ready to discuss younger siblings’ schedules as well, since concerns can carry over.
Communication also includes honest reporting about the system itself. The Ukraine authors recommended systematically identifying and documenting temperature excursions and assessing potential damage to vaccines as immediate actions.[4] In Indore, India, after an electronic vaccine intelligence network was implemented, functional power backup at cold chain points increased from 22.2% to 72.5%, and updated stock registers from 72.2% to 100%.[3] No cold chain point had a dedicated vaccine van or trained driver, a gap the authors said requires targeted action.[3]

Executive guidance · 90-day plan
Move from listening to a verified improvement in 90 days.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how National Infant Immunization Week communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Validate one access or transition route with patients, families, or authorized caregivers as locally appropriate.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how National Infant Immunization Week communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Validate one access or transition route with patients, families, or authorized caregivers as locally appropriate. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Carry one accountable improvement beyond the campaign window.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Listen to the people closest to the route, assign one barrier, and verify the change.
Executive action kit · Week observance
Turn National Infant Immunization Week into accountable action.
Use the observance to test whether prevention, readiness, escalation, and learning operate as one connected system.
Leadership focus
Use this observance to examine trustworthy information, prevention access, and community connection. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the family-centered information, access, coordination, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review caregiver language, disability access, transportation, digital access, school coordination, and differences in the ability to navigate the approved route.
Five-minute briefing
Inspect the operating sequence
Listen with children, families, pediatric teams, schools, community partners, and operational leaders. Find one a confusing entry point, an unacknowledged family concern, or a transition without a named owner, then test the locally approved route from entry through acknowledged follow-through.
- Identify the concern
- Activate prevention
- Include the family route
- Escalate and respond
- Review and improve
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined control checks, barriers, exceptions, and corrective-action status.
- Readiness checks, unavailable resources, response barriers, and escalations.
- Locally defined communication barriers, repeated contacts, support requests, unresolved handoffs, and experience feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Public Health and Community Partners
Staff communication template
During National Infant Immunization Week, our organization will connect awareness with a practical review of the family-centered information, access, coordination, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
National Infant Immunization Week is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Porter RM, Campos I, Shoaib M, Vogt TM, Orenstein W, Bednarczyk RA, et al. Respiratory Syncytial Virus Immunization Intention During Pregnancy and Infancy. JAMA Network Open. 2026;9(7):e2625117. https://doi.org/10.1001/jamanetworkopen.2026.25117
- 2.Kang CR, Choe S, Lee YH, Choe YJ, Choi WS, Noh JY, et al. Evaluation of Vaccine Cold Chain Practices in Healthcare Facilities of the Republic of Korea: A Multi-Site Cross-Sectional Study. Journal of Korean Medical Science. 2026;41(37):e240. https://doi.org/10.3346/jkms.2026.41.e240
- 3.Afrin S, Saroshe S, Mantri D, Dixit S. Assessment of Cold Chain Infrastructure and Vaccine Logistics Before and After eVIN Implementation at Cold Chain Points in Indore District: An Observational Study (2014–2021). Indian Journal of Community Medicine. 2026;51(4):680-685. https://doi.org/10.4103/ijcm.ijcm_444_25
- 4.Gaievskyi S, Grechukha Y, Khomenko O, Musa NMW, Benes O, Habicht J, et al. Assessing vaccine cold chain storage and transport in Ukraine: a cross-sectional study. BMC Health Services Research. 2026;26(1):534. https://doi.org/10.1186/s12913-026-14332-5
- 5.Yough MD, Ali AY, Murba AU, Melton MS, Abdelrahim K, Baba MM. Monitoring the infectious titer of bOPV and the vaccine vial monitor stage at different storage temperature ranges. Human Vaccines & Immunotherapeutics. 2026;22(1):2662762. https://doi.org/10.1080/21645515.2026.2662762
- 6.Almeida MG, Alves de Oliveira BF, de Melo Júnior EB, de Araújo Rodrigues AR, Lugo NF, Moura Borges PDT, et al. Knowledge as a predictor of parental vaccine hesitancy during children’s first year of life. Vaccine. 2026;92:129127. https://doi.org/10.1016/j.vaccine.2026.129127
- 7.Barton SM, Calhoun AW, Bohnert CA, Statler VA, Bichir NM, Bricken ML, et al. Effectiveness of Online Vaccine Communication Training and Assessment Using Virtual Encounters With Standardized Vaccine-Hesitant Parents. Cureus. 2026. https://doi.org/10.7759/cureus.107736
- 8.Yuan Q, Zhang W, Wang H, Gao P, Cao Z, Suo L. Vaccination coverage and influencing factors of four non‑National Immunization Program vaccines: A cross‑sectional survey among children aged 1‒6 years in Beijing, China. Human Vaccines & Immunotherapeutics. 2026;22(1):2664995. https://doi.org/10.1080/21645515.2026.2664995
- 9.Shah PD, Schwartz J, Bacci JL, Calo WA, Li L, Glascock M, et al. Pilot evaluation of a clinical decision support system package to facilitate proactive HPV vaccination in community pharmacies. Journal of the American Pharmacists Association. 2026:103533. https://doi.org/10.1016/j.japh.2026.103533
- 10.Pletnikoff PP, Aho S, Ohlsen EC, McLaughlin J. Higher Human Papillomavirus Vaccination Coverage Among American Indian and Alaska Native Adolescents and Rural Adolescents in Alaska. Journal of Community Health. 2026;51(5):805-812. https://doi.org/10.1007/s10900-026-01586-7
- 11.Decherong LK, Basilius MB, Cash McGinley HL, Kern-Allely S. Investigating HPV Vaccination in the Republic of Palau: Assessment of the School-Based Program from 2020 to 2024. Hawai‘i Journal of Health & Social Welfare. 2026;85(9):269. https://doi.org/10.62547/nnih2392
- 12.Kara-Aksay A, Özyurt G, Emir B, Özgül-Katırcıoğlu D, Erten-Almak T. Self-reported vaccine hesitancy and refusal among parents of children with autism spectrum disorder and other developmental delays: a cross-sectional study. European Journal of Pediatrics. 2026;185(7):508. https://doi.org/10.1007/s00431-026-07179-9
- 13.Wang H, Chen W, Gao P, Ma Q, Yuan Q, Cao Z, et al. Retrospective cohort study of hepatitis B immunization strategy effects in Beijing across 30 years. Nature Communications. 2026;17(1):1523. https://doi.org/10.1038/s41467-025-68243-w
- 14.Lv X, Long A, Chen Y, Fang H. Socioeconomic Disparities in Childhood Vaccination Coverage in the United States: Evidence from a Post-COVID-19 Birth Cohort. Vaccines. 2025;13(12):1256. https://doi.org/10.3390/vaccines13121256
- 15.Thaker J, Albers AN, Newcomer SR. Nurses’ perceptions, experiences, and practices regarding human papillomavirus vaccination: results from a cross-sectional survey in Montana. BMC Nursing. 2023;22(1):211. https://doi.org/10.1186/s12912-023-01379-6
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| U.S. coverage and disparities for the combined 7-vaccine series | [14] | 2025 | Executive opening | Survey-based national estimates for 2023; disparities statistically measurable but small in absolute terms. |
| RSV immunization intention and the effect of a strong recommendation | [1] | 2026 | Public communication | Self-reported intention from an online panel in April 2024; not observed uptake. |
| Long-term effectiveness of universal infant hepatitis B immunization | [13] | 2026 | Continuum of care | Retrospective cohort in one city; system data rather than trial evidence. |
| Coverage of self-funded vaccines and associated factors | [8] | 2026 | Current evidence | Cross-sectional survey in Beijing; self-funded vaccine context differs from U.S. programs. |
| Parental hesitancy in the first year of life | [6] | 2026 | Current evidence | Cross-sectional household survey in one Brazilian state; hesitancy mainly related to COVID-19 vaccine. |
| Hesitancy after a developmental diagnosis | [12] | 2026 | Equity and trust | Self-reported behavior in 154 parents at two hospitals; recall bias possible. |
| Consent-to-dose gaps and series completion | [11] [10] | 2026 | Current evidence | School-based and adolescent HPV programs; applied to infant schedules by analogy. |
| Immunization information system integration in pharmacies | [9] | 2026 | Continuum of care | Single-arm pilot in six pharmacies with 13 paired staff surveys; adolescent vaccine focus. |
| Reminder-recall adoption and nurse perceptions in Vaccines for Children clinics | [15] | 2023 | Continuum of care | Self-reported survey from one state, 2020 to 2021. |
| Cold chain monitoring, alarms and emergency preparedness | [2] [4] [3] | 2026 | Human infrastructure | Country-specific audits and monitoring studies outside the United States; one internally inconsistent backup-testing figure was not used. |
| Vaccine potency by storage temperature | [5] | 2026 | Access | Laboratory study of one oral vaccine; not directly generalizable to injectable infant vaccines. |
| Training clinicians to communicate with hesitant parents | [7] | 2026 | Human infrastructure | Residents in a simulated telemedicine setting; standardized patient ratings did not differ. |

About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.

